首页> 外文期刊>Tissue engineering, Part C. Methods >Directed trans-differentiation of thymus cells into parathyroid-like cells without genetic manipulation.
【24h】

Directed trans-differentiation of thymus cells into parathyroid-like cells without genetic manipulation.

机译:无需基因操作即可将胸腺细胞定向转分化为甲状旁腺样细胞。

获取原文
获取原文并翻译 | 示例
           

摘要

Replacement of a diseased organ with an autologously derived tissue is an ideal therapy for some medical problems. However, it is difficult to recreate many adult human tissues in vitro due to the functionally necessary architecture of most organs and the lack of understanding of methods to direct the development of the organ of interest. The parathyroid gland is ideal for in vitro organ development because this gland is relatively simple, is transplantable, and is commonly affected by a surgical complication rather than an autoimmune disease. We have investigated thymus as a source of autologous endoderm and parathyroid-like precursor cells. Human thymus cells were treated with a differentiation protocol we developed with human embryonic stem cells (The Bingham Protocol) that utilizes timed exposures to Activin A and soluble Sonic hedgehog (Shh). We incrementally changed the protocol to optimize the differentiation of the thymus cells into parathyroid-like cells. The final protocol used 50 ng/mL Activin A and 100 ng/mL Shh over 13 weeks. The differentiated cells expressed the parathyroid markers parathyroid hormone (PTH), calcium sensing receptor, chemokine receptor type-4 (CXCR4), and chorian-specific transcription factor (GCM2) as measured by reverse transcription-polymerase chain reaction and PTH enzyme-linked immunosorbent assay. Cultured thymus cells without Activin A or Shh exposure did not secrete PTH nor express similar markers. The differentiated cells released PTH, which was suppressed in response to increased calcium concentration. The chemically differentiated cells did not form tumors in immune-compromised mice. Our protocol recreated cells with markers of parathyroid tissue that responded as parathyroid cells to physiologic stimuli. This approach is a further step toward a strategy to restore parathyroid function using autologous cells that were directed to differentiate by nongenetic in vitro manipulation.
机译:用自体衍生的组织代替患病器官是解决某些医学问题的理想疗法。然而,由于大多数器官在功能上必需的结构以及对指导目的器官发育的方法缺乏了解,很难在体外重建许多成年人类组织。甲状旁腺是体外器官发育的理想选择,因为该腺相对简单,可移植,并且通常受外科手术并发症而非自身免疫性疾病的影响。我们已经调查了胸腺作为自体内胚层和甲状旁腺样前体细胞的来源。用我们利用人胚胎干细胞开发的分化方案(Bingham方案)处理人胸腺细胞,该方案利用定时暴露于激活素A和可溶性音速刺猬(Shh)。我们逐步更改了协议,以优化胸腺细胞向甲状旁腺样细胞的分化。最终方案在13周内使用了50 ng / mL激活素A和100​​ ng / mL Shh。通过逆转录聚合酶链反应和PTH酶联免疫吸附法测量,分化的细胞表达了甲状旁腺标志物甲状旁腺激素(PTH),钙敏感受体,4型趋化因子受体(CXCR4)和胆碱特异性转录因子(GCM2)。分析。没有激活素A或Shh暴露的培养的胸腺细胞不分泌PTH或表达类似的标记。分化的细胞释放出PTH,其响应于钙浓度增加而被抑制。化学分化的细胞在免疫受损的小鼠中没有形成肿瘤。我们的协议重新创建了具有甲状旁腺组织标志物的细胞,该标志物作为甲状旁腺细胞对生理刺激作出反应。该方法是朝着使用自体细胞恢复甲状旁腺功能的策略迈出的又一步,该自体细胞通过非基因体外操作定向分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号